Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / biontech gains antibody drug conjugate platform lice

BNTX - BioNTech gains antibody drug conjugate platform license from Chinese biotech

May, 28 2024 10:55 AM BioNTech SE

2024-05-28 10:55:50 ET

More on BioNTech

BioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Company
New COVID FLiRT variants spike as FDA delays key vaccine meeting
Moderna, BioNTech close with double-digit percentage gains amid bird flu fears
BioNTech SE 2024 Q1 - Results - Earnings Call Presentation
BioNTech SE (BNTX) Q1 2024 Earnings Call Transcript

For further details see:

BioNTech gains antibody drug conjugate platform license from Chinese biotech

Stock Information

Company Name:	BioNTech SE
Stock Symbol:	BNTX
Market:	NYSE
Website:	biontech.de

BNTX BNTX Quote BNTX Short BNTX News BNTX Articles BNTX Message Board

Get BNTX Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.